Morgan Stanley Q3 EPS Beats by $0.73 on $17.98B Revenue; Trust Co Raises Stake 63.9%
Diversified Trust Co increased its Q3 stake by 63.9% to a 48,243-share position worth $7.67M, while Vanguard and Fisher raised holdings, lifting institutional ownership to 84.19%. Morgan Stanley reported Q3 EPS of $2.80 (beat by $0.73) on $17.98B revenue (+18.5% YoY) and declared a $1.00 dividend ($4.00 annual, 2.2% yield).
1. Significant Institutional Stake Changes
During the third quarter, Diversified Trust Co increased its holdings in Morgan Stanley by 63.9%, acquiring an additional 18,800 shares to bring its total to 48,243 shares valued at $7.67 million. Meanwhile, Vanguard Group added 1.35 million shares in the second quarter, raising its position to 119.12 million shares worth $16.78 billion, and Fisher Asset Management boosted its stake by 3.2%, adding 749,150 shares to reach 24.05 million shares valued at $3.39 billion. Other notable moves included Norges Bank’s inaugural position valued at approximately $2.23 billion, Ameriprise Financial’s 2.9% increase to 13.44 million shares ($1.89 billion), and Charles Schwab Investment Management’s 0.3% uptick to 10.98 million shares ($1.55 billion). Institutional investors collectively own more than 84% of the company’s equity.
2. Q3 Earnings and Financial Metrics Exceed Estimates
For the quarter ended October 15, Morgan Stanley reported adjusted earnings per share of $2.80, surpassing consensus estimates by $0.73, and generated revenue of $17.98 billion, an 18.5% increase year-over-year and $1.56 billion above analyst forecasts. Return on equity reached 16.4% while net margin stood at 13.85%. The firm’s debt-to-equity ratio remains at 3.27, with both current and quick ratios at 0.79, underpinning its balance-sheet stability. Analysts now project full-year earnings of $8.56 per share.
3. Quarterly Dividend and Share Repurchase Update
The board approved a quarterly dividend of $1.00 per share, reflecting a $4.00 annualized payout and a 41.03% payout ratio. The dividend was paid on November 14 to shareholders of record as of October 31, delivering a yield of approximately 2.2%. The company continues its share repurchase program, recently completing repurchases totaling over $1.5 billion in the past twelve months to offset dilution and enhance per-share metrics.
4. Analyst Revisions and Insider Transactions
Research firms have raised price targets across the board, with Keefe, Bruyette & Woods lifting its target from $184 to $202 and Wolfe Research upgrading its rating to Outperform with a $198 target. UBS and JPMorgan also raised their targets to $165 and $157 respectively, leaving the consensus rating at Moderate Buy. In insider activity, CEO James Gorman sold 100,000 shares at an average price of $164.34, reducing his stake by nearly 15%, a transaction valued at $16.43 million disclosed in an SEC filing.